Zydus Life FDA Nod, BL Kashyap Order, Ion Exchange Contracts Drive Stock Focus

• Zydus Lifesciences' US FDA accepted resubmission for its Menkes disease drug (CUTX-101), setting a new PDUFA date of January 14, 2026.
• Ion Exchange India secured contracts worth Rs 205 crore from Rayzon Energy and INOX Solar for water treatment systems.
• B L Kashyap and Sons received a Rs 615.69 crore order from Sattva CKC for structural and civil work on a commercial project.
• Arvind SmartSpaces acquired a new residential project in Bengaluru with a top-line potential of Rs 550 crore.
• BNP Paribas SA sold a 14.6% stake in Geojit Financial Services, with ICICI Prudential, Bajaj Allianz, and others acquiring shares.

Why It Matters: Company news impacts stock performance, guiding investor decisions.